跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NRA-CANDESARTAN HCTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NRA-CANDESARTAN HCTZ
Authorized
STANDARD
NRA-CANDESARTAN HCTZ
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3e6e869a15affbde
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
3e6e869a15affbde
Drug Approval Canada Name
NRA-CANDESARTAN HCTZ
Product Name
NRA-CANDESARTAN HCTZ
Status
Marketed
Status Date
2023-07-20
Original Market Date
2023-07-20
Din
02531267
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09DA06 CANDERSARTAN AND DIURETICS
Atc Name
c 09 da 06
Aig Number
0244181003
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
HYDROCHLOROTHIAZIDE
25 MG
CANDESARTAN CILEXETIL
32 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3e6e869a15affbde
Type
Standard
Back to Health Canada Approvals